Safety first: evidence for delay of radical prostatectomy without use of androgen deprivation therapy during COVID-19.
作者信息
Sean Ong Xuan Rui, Condon Benjamin, Bagguley Dominic, Lawrentschuk Nathan, Azad Arun, Murphy Declan
机构信息
Division of Cancer Surgery, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.
EJ Whitten Foundation Prostate Cancer Research Centre, Epworth Health, Victoria, Australia.
出版信息
Future Oncol. 2020 Jul;16(20):1409-1411. doi: 10.2217/fon-2020-0388. Epub 2020 May 14.
Abstract
摘要
相似文献
1
Safety first: evidence for delay of radical prostatectomy without use of androgen deprivation therapy during COVID-19.安全第一：COVID-19期间不使用雄激素剥夺疗法而延迟根治性前列腺切除术的证据
Future Oncol. 2020 Jul;16(20):1409-1411. doi: 10.2217/fon-2020-0388. Epub 2020 May 14.
2
Oncology clinical trials in the time of COVID-19: how a pandemic can revolutionize patients' care.COVID-19 时代的肿瘤学临床试验：大流行如何彻底改变患者护理。
Future Oncol. 2020 Jul;16(20):1413-1415. doi: 10.2217/fon-2020-0364. Epub 2020 May 14.
3
Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532).雄激素剥夺疗法治疗前列腺癌与 SARS-CoV-2 感染风险的关系：一项基于人群的研究（N=4532）。
Ann Oncol. 2020 Aug;31(8):1040-1045. doi: 10.1016/j.annonc.2020.04.479. Epub 2020 May 6.
4
Sequencing Treatments for Cancer During the COVID-19 Pandemic.2019冠状病毒病大流行期间的癌症序贯治疗
Am J Clin Oncol. 2020 Jul;43(7):457-458. doi: 10.1097/COC.0000000000000717.
5
Emergency Open-source Three-dimensional Printable Ventilator Circuit Splitter and Flow Regulator during the COVID-19 Pandemic.COVID-19大流行期间的应急开源三维可打印呼吸机电路分流器和流量调节器
Anesthesiology. 2020 Jul;133(1):246-248. doi: 10.1097/ALN.0000000000003332.
6
Staying Ahead of the Wave.引领潮流。
N Engl J Med. 2020 Apr 30;382(18):e44. doi: 10.1056/NEJMc2009409. Epub 2020 Apr 13.
7
COVID-19 and The Prostate Cancer Connection.新型冠状病毒肺炎与前列腺癌的关联
Can J Urol. 2020 Oct;27(5):10346.
8
Does androgen deprivation therapy in patients with prostate cancer protect from COVID-19?前列腺癌患者接受雄激素剥夺治疗能预防新型冠状病毒肺炎吗？
Rev Assoc Med Bras (1992). 2020 Oct;66(10):1314-1315. doi: 10.1590/1806-9282.66.10.1314.
9
Androgen deprivation and SARS-CoV-2 in men with prostate cancer.前列腺癌男性患者的雄激素剥夺与新型冠状病毒肺炎
Ann Oncol. 2020 Oct;31(10):1417-1418. doi: 10.1016/j.annonc.2020.06.015. Epub 2020 Jun 29.
10
On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2.关于前列腺癌雄激素剥夺治疗与严重急性呼吸综合征冠状病毒2感染风险之间的关系。
Ann Oncol. 2020 Oct;31(10):1415-1416. doi: 10.1016/j.annonc.2020.06.005. Epub 2020 Jun 18.
引用本文的文献
1
A cohort analysis of patients receiving neoadjuvant androgen deprivation therapy prior to robot-assisted laparoscopic prostatectomy during the Covid-19 pandemic.对在新冠疫情期间接受机器人辅助腹腔镜前列腺切除术之前接受新辅助雄激素剥夺治疗的患者进行的队列分析。
J Clin Urol. 2023 Mar;16(2):131-139. doi: 10.1177/20514158211022216. Epub 2021 Jun 7.
2
Determinants of COVID-19 Outcome as Predictors of Delayed Healthcare Services among Adults ≥50 Years during the Pandemic: 2006-2020 Health and Retirement Study.COVID-19 结局的决定因素预测了疫情期间 50 岁及以上成年人延迟医疗服务的情况：2006-2020 年健康与退休研究。
Int J Environ Res Public Health. 2022 Sep 23;19(19):12059. doi: 10.3390/ijerph191912059.
3
Implications of COVID-19 on urological laparoscopic surgery.新型冠状病毒肺炎对泌尿外科腹腔镜手术的影响
Future Oncol. 2020 Sep;16(26):1941-1945. doi: 10.2217/fon-2020-0533. Epub 2020 Jun 27.
本文引用的文献
1
Incidence of the adverse effects of androgen deprivation therapy for prostate cancer: a systematic literature review.雄激素剥夺疗法治疗前列腺癌不良反应的发生率：系统文献复习。
Support Care Cancer. 2020 May;28(5):2079-2093. doi: 10.1007/s00520-019-05255-5. Epub 2020 Jan 7.
2
Prostate cancer outcomes and delays in care.前列腺癌的治疗结果与治疗延迟
Int Urol Nephrol. 2017 Mar;49(3):449-455. doi: 10.1007/s11255-017-1508-z. Epub 2017 Jan 12.
3
Evaluating the effect of time from prostate cancer diagnosis to radical prostatectomy on cancer control: Can surgery be postponed safely?评估前列腺癌诊断至根治性前列腺切除术的时间对癌症控制的影响：手术可以安全推迟吗？
Urol Oncol. 2017 Apr;35(4):150.e9-150.e15. doi: 10.1016/j.urolonc.2016.11.010. Epub 2016 Dec 13.
4
A Decade of Active Surveillance in the PRIAS Study: An Update and Evaluation of the Criteria Used to Recommend a Switch to Active Treatment.PRIAS 研究中的十年主动监测：更新和评估推荐转为主动治疗的标准。
Eur Urol. 2016 Dec;70(6):954-960. doi: 10.1016/j.eururo.2016.06.007. Epub 2016 Jun 19.
5
Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer.一项针对低危前列腺癌的前瞻性主动监测计划的中期和长期结果。
J Clin Oncol. 2015 Oct 20;33(30):3379-85. doi: 10.1200/JCO.2015.62.5764. Epub 2015 Aug 31.
6
Long-term follow-up of a large active surveillance cohort of patients with prostate cancer.前列腺癌大型主动监测队列患者的长期随访。
J Clin Oncol. 2015 Jan 20;33(3):272-7. doi: 10.1200/JCO.2014.55.1192. Epub 2014 Dec 15.
7
Effect of delaying surgery on radical prostatectomy outcomes: a contemporary analysis.延迟手术对根治性前列腺切除术结果的影响：一项当代分析。
BJU Int. 2012 Jul;110(2):211-6. doi: 10.1111/j.1464-410X.2011.10666.x. Epub 2011 Nov 16.
8
Delay of surgery in men with low risk prostate cancer.低危前列腺癌患者的手术延迟。
J Urol. 2011 Jun;185(6):2143-7. doi: 10.1016/j.juro.2011.02.009. Epub 2011 Apr 15.
9
Outcome of primary versus deferred radical prostatectomy in the National Prostate Cancer Register of Sweden Follow-Up Study.瑞典前列腺癌登记随访研究中，初始根治性前列腺切除术与延期根治性前列腺切除术的结果比较。
J Urol. 2010 Oct;184(4):1322-7. doi: 10.1016/j.juro.2010.06.008. Epub 2010 Aug 17.
10
The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.前列腺癌干预与观察试验：退伍军人事务部/美国国立癌症研究所/医疗保健研究与质量局合作研究项目#407（PIVOT）：一项随机对照试验的设计及基线结果，该试验比较了根治性前列腺切除术与对临床局限性前列腺癌男性进行观察等待的效果。
Contemp Clin Trials. 2009 Jan;30(1):81-7. doi: 10.1016/j.cct.2008.08.002. Epub 2008 Aug 23.
Zotero 插件